CPHA Canvax

"Influenza vaccine production using mammalian cell culture-based technology is an innovative technique that may offer enhanced manufacturing scalability and sterility and, thus, a potentially valuable alternative to overcome some of the problems and vulnerabilities associated with egg-based production." - Supplemental Statement – Mammalian Cell Culture-Based Influenza Vaccines

Rating See Comments Ratings


Vaccine Safety and Development,Research and Development,Vaccine Technology and New Vaccines,Vaccine Effectiveness and Efficacy,Vaccine Preventable Diseases,Communicable Diseases,Influenza Vaccine Safety and Development
Research and Development
Vaccine Technology and New Vaccines
Vaccine Effectiveness and Efficacy
Vaccine Preventable Diseases
Communicable Diseases


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.